BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 29980193)

  • 1. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
    Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
    Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
    Sun W; Zu S; Shao G; Wang W; Gong F
    J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the 14-3-3σ is essential for LASP1-mediated colorectal cancer progression via activating PI3K/AKT signaling pathway.
    Shao Z; Cai Y; Xu L; Yao X; Shi J; Zhang F; Luo Y; Zheng K; Liu J; Deng F; Li R; Zhang L; Wang H; Li M; Ding Y; Zhao L
    Sci Rep; 2016 May; 6():25631. PubMed ID: 27156963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression.
    Dejima T; Imada K; Takeuchi A; Shiota M; Leong J; Tombe T; Tam K; Fazli L; Naito S; Gleave ME; Ong CJ
    Prostate; 2017 Feb; 77(3):309-320. PubMed ID: 27775154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guggulsterone from Commiphora mukul potentiates anti-glioblastoma efficacy of temozolomide in vitro and in vivo via down-regulating EGFR/PI3K/Akt signaling and NF-κB activation.
    Xu HB; Chen XZ; Yu ZL; Xue F
    J Ethnopharmacol; 2023 Jan; 301():115855. PubMed ID: 36280019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LASP1 promotes glioma cell proliferation and migration and is negatively regulated by miR-377-3p.
    Liu Y; Gao Y; Li D; He L; Iw L; Hao B; Chen X; Cao Y
    Biomed Pharmacother; 2018 Dec; 108():845-851. PubMed ID: 30372896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.
    Gao Q; Tang L; Wu L; Li K; Wang H; Li W; Wu J; Li M; Wang S; Zhao L
    Cell Death Dis; 2018 Mar; 9(3):393. PubMed ID: 29531214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of silencing LASP1 on biological behaviors of oral squamous cell carcinoma cells and IC50 of three anti-tumor drugs].
    Chen Q; Wang X; Yu YC; Wei KJ
    Shanghai Kou Qiang Yi Xue; 2019 Feb; 28(1):13-19. PubMed ID: 31080993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
    Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
    J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
    Ni H; Ji D; Huang Z; Li J
    Arch Biochem Biophys; 2020 Nov; 695():108628. PubMed ID: 33049294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway.
    Mu Q; Wang L; Yu F; Gao H; Lei T; Li P; Liu P; Zheng X; Hu X; Chen Y; Jiang Z; Sayari AJ; Shen J; Huang H
    Cancer Biol Ther; 2015; 16(4):623-33. PubMed ID: 25719943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
    Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
    Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme.
    Mohajerani F; Tehrankhah ZM; Rahmani S; Afsordeh N; Shafiee S; Pourgholami MH; Soltani BM; Sadeghizadeh M
    BMC Cancer; 2024 Jan; 24(1):19. PubMed ID: 38167030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells].
    Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213
    [No Abstract]   [Full Text] [Related]  

  • 20. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
    Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
    J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.